Sumitomo Mitsui Trust Group Inc. Takes $102.62 Million Position in Healthpeak Properties, Inc. (NYSE:DOC)

Sumitomo Mitsui Trust Group Inc. bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the 3rd quarter, Holdings Channel reports. The firm bought 4,486,881 shares of the real estate investment trust’s stock, valued at approximately $102,615,000.

Other large investors have also recently made changes to their positions in the company. HM Payson & Co. purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $25,000. S.A. Mason LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $26,000. Rise Advisors LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $29,000. Fortitude Family Office LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $32,000. Finally, Barrett & Company Inc. purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $33,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

Shares of DOC opened at $21.65 on Thursday. The firm has a market cap of $15.14 billion, a PE ratio of 46.06, a P/E/G ratio of 2.43 and a beta of 1.13. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm has a fifty day simple moving average of $22.30 and a two-hundred day simple moving average of $21.03. Healthpeak Properties, Inc. has a 1-year low of $16.01 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). The company had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The company’s revenue for the quarter was up 25.9% on a year-over-year basis. During the same quarter last year, the company earned $0.45 earnings per share. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.54%. Healthpeak Properties’s payout ratio is presently 255.32%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on DOC. Evercore ISI boosted their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. Scotiabank upped their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research report on Monday, September 9th. Robert W. Baird upped their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $23.00 price objective (up from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Finally, Citigroup upped their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $22.86.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.